Related Experiment Video
Updated: Mar 8, 2026
A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
How to prevent the microvascular complications of type 2 diabetes beyond glucose control
Willy Marcos Valencia1,2, Hermes Florez2,3,4
1Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL 33125, USA willy.valencia-rodrigo@va.gov.
Abstract:
Microvascular complications (retinopathy, nephropathy, and neuropathy) affect hundreds of millions of patients with type 2 diabetes. They usually affect people with longstanding or uncontrolled disease, but they can also be present at diagnosis or in those yet to have a diagnosis made. The presentation and progression of these complications can lead to loss of visual, renal, and neurologic functions, impaired mobility and cognition, poor quality of life, limitations for employment and productivity, and increased costs for the patient and society. If left uncontrolled or untreated, they lead to irreversible damage and even death. This review focuses on the primary and secondary prevention of diabetic microvascular complications in patients with type 2 diabetes, beyond glycemic control. Interventions discussed include standard of care interventions supported by guidelines from major organizations, as well as additional proposed interventions that are supported by research published in the past decade. High level evidence sources such as systematic reviews and large, multicenter randomized clinical trials have been prioritized. Smaller trials were included where high quality evidence was unavailable.
Insights
Preventing diabetic microvascular complications like retinopathy and nephropathy in type 2 diabetes is crucial. This review explores interventions beyond blood sugar control for primary and secondary prevention.
Area of Science:
- Endocrinology and Metabolism
- Nephrology
- Ophthalmology
- Neurology
Background:
- Diabetic microvascular complications (retinopathy, nephropathy, neuropathy) impact millions with type 2 diabetes.
- These complications can manifest at diagnosis or later, leading to severe functional loss and reduced quality of life.
- Uncontrolled complications result in irreversible damage and increased mortality.
Purpose of the Study:
- To review primary and secondary prevention strategies for diabetic microvascular complications in type 2 diabetes.
- To focus on interventions beyond glycemic control, incorporating recent research.
- To prioritize evidence from high-level sources like systematic reviews and large clinical trials.
Main Methods:
- Systematic review of literature focusing on primary and secondary prevention.
- Inclusion of standard of care interventions and novel proposed interventions.
- Prioritization of evidence from high-level sources (systematic reviews, large RCTs) and inclusion of smaller trials where necessary.
Main Results:
- Discusses guideline-supported standard of care interventions.
- Highlights additional proposed interventions supported by recent research.
- Emphasizes the importance of a multi-faceted approach to prevention.
Conclusions:
- Effective prevention of diabetic microvascular complications requires strategies beyond glycemic control.
- Early and comprehensive intervention is key to mitigating long-term damage and improving patient outcomes.
- Further research into novel interventions can enhance current prevention paradigms.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
01:15Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:22Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:15Diabetes: Symptoms, Diagnosis, and Complications
01:20Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
01:36Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...